Literature DB >> 15385149

Cytokeratin expression in primary epithelial cell culture from bovine conjunctiva.

G Paladino1, C Marino, S La Terra Mulè, C Civiale, D Rusciano, V Enea.   

Abstract

Aim of the present study is to extend our previous observations on a model of primary epithelial cell culture obtained from bovine conjunctiva, and analyse the maintenance of the conjunctival phenotype, relative to cytokeratin (CK) expression, through extended periods of cultivation under different conditions. Conjunctival epithelial cells were grown in transwell filters, and cultured either under liquid covered (LC), or air-interface (AI) conditions. The physiological state of the cells was monitored daily by measurement of the trans-epithelial electrical resistance (TEER). Analysis of cytokeratin expression was then carried out at different time points (up until 14 days), and compared to the original profile of the conjunctival tissue in order to assess deviations from the primitive phenotype. Immunodetection studies, carried out by both western immunoblot and immunofluorescence analyses, revealed constant expression of the pan-epithelial marker AE3 (recognizing basic type cytokeratins), confirming the epithelial nature of the culture. Other cytokeratins characteristic of non-keratinized stratified epithelia (CK4 and CK13) were absent in corneal tissue, while in conjunctival epithelial cells were more expressed under AI than under LC culture conditions. Expression of CK12, a specific marker of corneal tissue, revealed by the antibody AE5, was never observed in conjunctival epithelial cells. These results indicate that the conjunctival phenotype is conserved during extended periods of culturing, making this system a reliable substitute of conjunctival tissue for pharmaceutical analyses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385149     DOI: 10.1016/j.tice.2004.05.003

Source DB:  PubMed          Journal:  Tissue Cell        ISSN: 0040-8166            Impact factor:   2.466


  7 in total

Review 1.  Epithelial stem cells of the eye surface.

Authors:  R P Revoltella; S Papini; A Rosellini; M Michelini
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

2.  Development and characterization of an organotypic model of Barrett's esophagus.

Authors:  Rachelle E Kosoff; Kristin L Gardiner; Lauren M F Merlo; Kirill Pavlov; Anil K Rustgi; Carlo C Maley
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

3.  Corneal goblet cells and their niche: implications for corneal stem cell deficiency.

Authors:  Ahdeah Pajoohesh-Ganji; Sonali Pal-Ghosh; Gauri Tadvalkar; Mary Ann Stepp
Journal:  Stem Cells       Date:  2012-09       Impact factor: 6.277

4.  Evidence that Clostridium perfringens Enterotoxin-Induced Intestinal Damage and Enterotoxemic Death in Mice Can Occur Independently of Intestinal Caspase-3 Activation.

Authors:  John C Freedman; Mauricio A Navarro; Eleonora Morrell; Juliann Beingesser; Archana Shrestha; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

Review 5.  The Communication between Ocular Surface and Nasal Epithelia in 3D Cell Culture Technology for Translational Research: A Narrative Review.

Authors:  Malik Aydin; Jana Dietrich; Joana Witt; Maximiliane S C Finkbeiner; Jonas J-H Park; Stefan Wirth; Christine E Engeland; Friedrich Paulsen; Anja Ehrhardt
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

6.  Ocular Drug Delivery; Impact of in vitro Cell Culture Models.

Authors:  Jaleh Barar; Masoud Asadi; Seyed Abdolreza Mortazavi-Tabatabaei; Yadollah Omidi
Journal:  J Ophthalmic Vis Res       Date:  2009-10

7.  Determining the Depth of Injury in Bioengineered Tissue Models of Cornea and Conjunctiva for the Prediction of All Three Ocular GHS Categories.

Authors:  Michaela Zorn-Kruppa; Pia Houdek; Ewa Wladykowski; Maria Engelke; Melinda Bartok; Karsten R Mewes; Ingrid Moll; Johanna M Brandner
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.